EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Detrimental Effects of β2‐Microglobulin on Muscle Metabolism: Evidence From In Vitro, Animal and Human Research

Shibo Wei, So Jeong Park, Eunah Choi, Il-Young Jang, Yan Zhang, Yingqi Xue, Yunju Jo, Hee-Won Jung, Eunhye Ji, Jin Young Lee, Yujin Moon, Eunju Lee und 2 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.13745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Shibo Wei und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: beta 2-Microglobulin, Muscle, Skeletal, Sarcopenia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare, Republic of Korea, MSIT, Korea Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background β2‐Microglobulin (B2M) has garnered considerable interest as a potential pro‐ageing factor, leading to speculation about its involvement in muscle metabolism and the development of sarcopenia, a key component of ageing phenotypes. To explore this hypothesis, we conducted a comprehensive investigation into the impact of B2M on cellular and animal muscle biology, as well as its clinical implications concerning sarcopenia parameters in older individuals.

Methods

In vitro myogenesis was induced in mouse C2C12 myoblasts with 2% horse serum. For in vivo research, C57BL/6 mice aged 3 months were intraperitoneally given 250 μg of B2M daily, and muscular alterations were assessed one month later. Human blood samples were obtained from 158 participants who underwent assessments of muscle mass and function at an outpatient geriatric clinic affiliated with a teaching hospital. Sarcopenia and associated parameters were assessed using cut‐off values specifically tailored for the Asian population. The concentration of serum B2M was quantified through an enzyme‐linked immunosorbent assay.

Results

Recombinant B2M inhibited in vitro myogenesis by increasing intracellular reactive oxygen species (ROS) production. Furthermore, B2M significantly induced differential myotube atrophy via ROS‐mediated ITGB1 downregulation, leading to impaired activation of the FAK/AKT/ERK signalling cascade and enhanced nuclear translocation of FoxO transcription factors. Animal experiments showed that mice with systemic B2M treatment exhibited significantly smaller cross‐sectional area of tibialis anterior and soleus muscle, weaker grip strength, shorter grid hanging time, and decreased latency time to fall off the rotating rod, compared to untreated controls. In a clinical study, serum B2M levels were inversely associated with grip strength, usual gait speed and short physical performance battery (SPPB) total score after adjustment for age, sex, and body mass index, whereas sarcopenia phenotype score showed a positive association. Consistently, higher serum B2M levels were associated with higher risk for weak grip strength, slow gait speed, low SPPB total score, and poor physical performance.

Conclusion

These results provide experimental evidence that B2M exerted detrimental effects on muscle metabolism mainly by increasing oxidative stress. Furthermore, we made an effort to translate the results of in vitro and animal research into clinical implication and found that circulating B2M could be one of blood‐based biomarkers to assess poor muscle health in older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta 2-MicroglobulinMuscle, SkeletalSarcopeniaAnimalsHumansMiceMaleFemaleAgedMuscle DevelopmentReactive Oxygen SpeciesMice, Inbred C57BLAged, 80 and over

Stichwörter der Autor:innen

ageingbiomarkerpro‐ageing factorsarcopeniaβ2‐microglobulin

Substanzen

beta 2-MicroglobulinReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea.
  • Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Division of Geriatrics, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Sarcopenia Total Solution Center, Wonkwang University School of Medicine, Iksan, Republic of Korea.

ORCID-Profile: Beom-Jun Kim

Förderung

  • Ministry of Health and Welfare, Republic of Korea
  • MSIT
  • Korea Medical Institute
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Wei, S., Park, S. J., Choi, E., Jang, I. Y., Zhang, Y., Xue, Y., Jo, Y., Jung, H. W., Ji, E., Lee, J. Y., Moon, Y., Lee, E., Ryu, D., & Kim, B. J. (2025). Detrimental Effects of β2‐Microglobulin on Muscle Metabolism: Evidence From In Vitro, Animal and Human Research. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13745

Vancouver

Wei S, Park SJ, Choi E, Jang IY, Zhang Y, Xue Y, et al. Detrimental Effects of β2‐Microglobulin on Muscle Metabolism: Evidence From In Vitro, Animal and Human Research. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13745

BibTeX
@article{Wei2025,
  author = {Wei, Shibo and Park, So Jeong and Choi, Eunah and Jang, Il-Young and Zhang, Yan and Xue, Yingqi and Jo, Yunju and Jung, Hee-Won and Ji, Eunhye and Lee, Jin Young and Moon, Yujin and Lee, Eunju and Ryu, Dongryeol and Kim, Beom-Jun},
  title = {Detrimental Effects of β2‐Microglobulin on Muscle Metabolism: Evidence From In Vitro, Animal and Human Research},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.13745}
}
Kostenlos starten →